Lexology February 20, 2025
Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.
Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.
- Olympus Partners completed the acquisition of PAI Pharma, an industry leader in the manufacturing and distribution of generic oral liquids in ready-to-dose cups and bottles. PAI Pharma boasts the broadest portfolio of generic oral liquid medicines in the U.S....
Today's Sponsors
Today's Sponsor